Larry Liberti


Dr Liberti has worked in pharmaceutical regulatory affairs, communications and clinical R&D for the pple University Graduate School of RAQA. He is a volunteer Director of the non-profit Erudee Foundation and RAPS. He received his doctorate in International Regulatory Policy from Utrecht University where his research centred on expedited regulatory pathways with applicability in emerging markets. ast four decades. He was the Executive Director of CIRL and is now an adjunct professor at the Tem